To estimate lipid profile in patients with copd

Chronic obstructive pulmonary disease (COPD) is an obstructive lung condition categorised by limitation of air flow in lungs which is usually advanced and is related with reactions due to severe inflammation in the lungs more likely because of toxic elements. It interferes with normal breathing and is not fully reversible. Chronic bronchitis (cough and sputum for 3 or more than 3 months in each of two consecutive years) and emphysema (abnormal permanent enlargement of air passages with destruction of their walls without obvious fibrosis) is related with the diagnosis of COPD. A life threatening under diagnosed disease COPD is also known as smoker’s cough. The COPD is predicted to be the third furthermost important reason of mortality by World Health Organisation by 2030. WHO knows that COPD carries much value in matters of public health. Smoking is a major risk factor and smoking is known to have hyperlipidemic effects. Oxidative stress is implicated in COPD which initiate inflammatory responses in the lungs. Effects other than pulmonary effects include weight loss and skeletal muscle dysfunction.